Late-Onset Aicardi-Goutières Syndrome: A Characterization of Presenting Clinical Features
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Pediatric Neurology
- Vol. 115, 1-6
Abstract
No abstract availableKeywords
Funding Information
- National Center for Advancing Translational Sciences
- National Institute of Neurological Disorders and Stroke
This publication has 31 references indexed in Scilit:
- RNase H2, mutated in Aicardi‐Goutières syndrome, promotes LINE‐1 retrotranspositionThe EMBO Journal, 2018
- LINE1 contributes to autoimmunity through both RIG-I- and MDA5-mediated RNA sensing pathwaysJournal of Autoimmunity, 2018
- Neuroradiologic patterns and novel imaging findings in Aicardi-Goutières syndromeNeurology, 2016
- Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1American Journal of Medical Genetics Part A, 2015
- Mutations in ADAR1, IFIH1, and RNASEH2B Presenting As Spastic ParaplegiaNeuropediatrics, 2014
- Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signalingNature Genetics, 2014
- A type I interferon signature identifies bilateral striatal necrosis due to mutations in ADAR1Journal of Medical Genetics, 2013
- Modulation of LINE-1 and Alu/SVA Retrotransposition by Aicardi-Goutières Syndrome-Related SAMHD1Cell Reports, 2013
- The TREX1 Exonuclease R114H Mutation in Aicardi-Goutières Syndrome and Lupus Reveals Dimeric Structure Requirements for DNA Degradation ActivityJournal of Biological Chemistry, 2011
- A Progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosisAnnals of Neurology, 1984